Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/1999
12/16/1999WO1999064856A1 Method and device for measuring moisture in structural material
12/16/1999WO1999064855A1 Process for monitoring the concentration of metallic impurities in a wafer cleaning solution
12/16/1999WO1999064849A1 Measuring apparatus for ion activity
12/16/1999WO1999064847A1 Electrochemical probes for detection of molecular interactions and drug discovery
12/16/1999WO1999064846A1 Analyzer
12/16/1999WO1999064843A1 Method for determining the content of predetermined ingredients with stochastic distribution in goods which are of a solid and nonhomogeneous consistency
12/16/1999WO1999064839A1 Automatic analysis apparatus used for timing blood coagulation
12/16/1999WO1999064835A2 Screening method for dehydrogenase oligomerisation modulators
12/16/1999WO1999064814A1 Method and apparatus for determining processing chamber cleaning or wafer etching endpoint
12/16/1999WO1999064690A1 Fire-resisting wall
12/16/1999WO1999064675A1 Methods for modeling two-dimensional responses of cross-machine direction actuators in sheet-forming processes
12/16/1999WO1999064633A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999WO1999064625A2 Methods and kits for discovery of rna-binding compounds
12/16/1999WO1999064622A1 Inhibition of coagulation in blood and blood products
12/16/1999WO1999064621A1 Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same
12/16/1999WO1999064620A2 Diagnostic assay requiring a small sample of biological fluid
12/16/1999WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
12/16/1999WO1999064594A2 Genes and gene expression products that are differentially regulated in prostate cancer
12/16/1999WO1999064592A2 Green fluorescent proteins for measuring the ph of a biological sample
12/16/1999WO1999064591A1 Antibody against lar phosphatase subunit
12/16/1999WO1999064589A1 Human receptor tyrosine kinase
12/16/1999WO1999064586A2 Phagocytic assay method
12/16/1999WO1999064585A2 Novel angiotensin receptor, production and use thereof
12/16/1999WO1999064578A1 Stabilized transient gene expression
12/16/1999WO1999064572A2 Poly(adp-ribose) polymerase gene
12/16/1999WO1999064567A1 Transformed cell lines which express heterologous g-protein-coupled receptors
12/16/1999WO1999064561A2 Method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition
12/16/1999WO1999064560A1 Methods for monitoring the stability of protein or cellular product secretion by cells in a fermenter culture
12/16/1999WO1999064559A2 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device
12/16/1999WO1999064519A1 Energy transfer assay method and reagent
12/16/1999WO1999064504A1 Nanoporous interpenetrating organic-inorganic networks
12/16/1999WO1999064463A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
12/16/1999WO1999064461A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
12/16/1999WO1999064458A1 Novel methods for identifying modulators of mitochondrial anion carrier activity
12/16/1999WO1999064452A1 Gpr35a receptor
12/16/1999WO1999064447A1 Solution-phase elisa
12/16/1999WO1999064446A1 Pyrazinone protease inhibitors
12/16/1999WO1999064439A2 Methods for increasing cationic antimicrobial peptides
12/16/1999WO1999064435A1 The human kidney specific gene kk86
12/16/1999WO1999064071A1 A method for preparing a carbonized resin dna immunoadsorbent
12/16/1999WO1999064067A2 Vaccine
12/16/1999WO1999064057A1 Retinoic acid inducible dna sequences from lung cells
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999WO1999064045A1 Novel therapeutic agents for membrane transporters
12/16/1999WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064017A1 Method and system for production and collection of lavage induced stool (lis) for chemical and biologic tests of cells
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063984A1 Novel sodium channel drugs and uses
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063932A2 Multibinding agents that modulate the 5-ht transporter
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999WO1999063904A2 Method, device and agents for removing caries in a cavity
12/16/1999WO1999063885A1 Iontophoresis device structural body and method for detecting in-vivo component
12/16/1999WO1999057321A8 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
12/16/1999WO1999057253A3 Crystallizable jnk complexes
12/16/1999WO1999056790A3 13c glucose breath test for the diagnosis of diabetes
12/16/1999WO1999054467A9 Sh2 domain-containing peptides
12/16/1999WO1999052947A3 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
12/16/1999WO1999049015A3 Cardiac-derived stem cells
12/16/1999WO1999048908A3 NGF TrkA RECEPTOR IMMUNOREACTIVE POLYPEPTIDE AND USES
12/16/1999WO1999046380A3 Human membrane spanning proteins
12/16/1999WO1999044030A9 Automated molecular pathology apparatus having independent slide heaters
12/16/1999WO1999041375A3 Human receptor proteins